Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
VYNE VYNE Therapeutics
- 1.340
- -0.090-6.29%
Trading May 6 14:30 ET
20.38MMarket Cap-1.44P/E (TTM)
1.430High1.340Low64.40KVolume1.400Open1.430Pre Close90.16KTurnover0.61%Turnover RatioLossP/E (Static)15.21MShares4.30052wk High0.39P/B14.18MFloat Cap1.27052wk Low--Dividend TTM10.58MShs Float2869.920Historical High--Div YieldTTM6.29%Amplitude1.270Historical Low1.399Avg Price1Lot Size
About VYNE Therapeutics Company
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Bridgewater, NJ.
Company Profile
SymbolVYNE
Company NameVYNE Therapeutics
Listing DateJan 25, 2018
Issue Price17.00
Founded2011
CEOMr. David Domzalski
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address685 Route 202/206 North,Suite 301
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807
Phone1-800-755-7936
Company Executives
- Name
- Position
- Salary
- David Domzalski
- President, Chief Executive Officer and Director
- 2.72M
- Mutya Harsch
- General Counsel, Chief Legal Officer and Secretary
- 1.13M
- Tyler Zeronda
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Dr. Iain A. Stuart, PhD
- Chief Scientific Officer
- 1.16M
- Sharon Barbari
- Independent Director
- 116.10K
- Elisabeth A. Sandoval Little
- Independent Director
- 108.60K
- Steven L. Basta
- Independent Director
- 83.60K
- Patrick G. LePore
- Lead Independent Director
- 123.60K
- Anthony D Bruno
- Independent Director
- 101.10K
- Dr. Christine Borowski, PhD
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
